Facilities And Capital Considerations For Continuous Manufacturing
Source: Bioprocess Online
We entertained several audience questions during our recent Bioprocess Online Live event Process Optimization or Full-Scale Automation. In this segment from the virtual event, David Bruehlmann addresses questions about facility considerations for continuous manufacturing, highlighting findings from Amgen and that indicate continuous enabled a considerably smaller facility footprint than batch. Considerations for new facility investment decisions.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more